UBS Upgrades Adient (ADNT) to Buy
Tweet Send to a Friend
UBS analyst Joseph Spak upgraded Adient (NYSE: ADNT) from Neutral to Buy with a price target of $30.00 (from $22.00).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


